Womed

Womed is an active French biotech-medical device company specializing in women’s reproductive health. Its flagship product—a bioresorbable hydrogel barrier gel—is designed to prevent intrauterine adhesions following surgical procedures such as hysteroscopy. The product has achieved CE marking and demonstrated efficacy/safety through European clinical trials, positioning the company at late-stage development/commercialization within Europe and preparing for global expansion. The company's work addresses a significant unmet need within gynecology by reducing infertility risk associated with post-surgical scarring, leveraging proprietary biomaterial technology.